7月24日，康方生物盘中下跌3.11%，报99.6港元/股，成交额4.5亿港元。此前两个交易日，公司因海外合作伙伴Summit公布依沃西全球III期HARMONi研究OS数据更新（ITT人群及西方人群OS HR均改善至0.76），股价累计上涨超13%，今日出现获利回吐。
板块方面，生物科技行业今日整体偏弱，荣昌生物跌3.78%，三生制药跌2.11%，科伦博泰生物跌0.96%，信达生物跌0.49%，仅百济神州逆势涨3.3%，板块回调形成共振压力。基本面上，依沃西跨人种疗效一致性已获验证，数据已提交FDA支持BLA审评，中长期全球注册价值未发生变化。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.